Anaplastic Oligodendroglioma
generalA WHO grade 3 oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).
28
Centers
21
Active Trials
$2M
Cancer Funding
Top Centers for Anaplastic Oligodendroglioma(28)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive High-Volume Research Center | 74.3 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 68.8 |
| 3 | NCI Clinical Active Research Program | 68.8 |
| 4 | University of Illinois Cancer CenterChicago, IL Active Research Program | 68.8 |
| 5 | Boston University Cancer CenterBoston, MA Active Research Program | 68.8 |
| 6 | Cancer Center at IllinoisUrbana, IL Active Research Program | 68.8 |
| 7 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 68.8 |
| 8 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 56.8 |
| 9 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 56.8 |
| 10 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 56.8 |
| 11 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 56.8 |
| 12 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 56.8 |
| 13 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 56.8 |
| 14 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 56.8 |
| 15 | BC CancerVancouver, BC Active Research Program | 56.8 |
| 16 | NCI Comprehensive | 39.1 |
| 17 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 39.1 |
| 18 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 39.1 |
| 19 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 39.1 |
| 20 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 39.1 |
| 21 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | 39.1 |
| 22 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 39.1 |
| 23 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 39.1 |
| 24 | NCI Comprehensive | 39.1 |
| 25 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 39.1 |
| 26 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 39.1 |
| 27 | 39.1 | |
| 28 | University of Texas Medical Branch Cancer CenterGalveston, TX | 39.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →